CCP
CELG

Corient Capital Partners’s Celgene Corp CELG Stock Holding History

Corient Capital Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-19,817
Closed -$1.97M – 497
2019
Q3 		$1.97M Sell
19,817
-593
-3% -$56.3K 0.28% 80
2019
Q2 		$1.89M Sell
20,410
-2,119
-9% -$201K 0.29% 83
2019
Q1 		$2.13M Sell
22,529
-2,586
-10% -$226K 0.35% 75
2018
Q4 		$1.61M Sell
25,115
-9,331
-27% -$689K 0.29% 104
2018
Q3 		$3.08M Hold
34,446
– – 0.51% 50
2018
Q2 		$2.74M Buy
34,446
+3,301
+11% +$274K 0.48% 63
2018
Q1 		$2.78M Buy
31,145
+28,526
+1,089% +$2.74M 0.51% 49
2017
Q4 		$273K Sell
2,619
-578
-18% -$65.2K 0.05% 248
2017
Q3 		$467K Buy
3,197
+49
+2% +$6.67K 0.09% 185
2017
Q2 		$409K Sell
3,148
-20
-0.6% -$2.45K 0.06% 224
2017
Q1 		$394K Sell
3,168
-390
-11% -$46.7K 0.06% 222
2016
Q4 		$412K Sell
3,558
-885
-20% -$98.6K 0.07% 219
2016
Q3 		$464K Buy
+4,443
New +$481K 0.09% 199

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Corient Capital Partners's CELG Position: Q4 2019 in Review

Corient Capital Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 19,817 shares — an estimated $1.97M sold.

Corient Capital Partners first reported a position in CELG in Q3 2016 and held it in 13 quarters. The position peaked at $3.08M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Corient Capital Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Corient Capital Partners sold 19,817 Celgene Corp shares in Q4 2019, an estimated $1.97M.
  • Corient Capital Partners first reported a position in Celgene Corp in Q3 2016 and held it in 13 quarters.
  • Corient Capital Partners's Celgene Corp position peaked at $3.08M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Corient Capital Partners's 13F filing for Q4 2019, filed 4 Feb 2020.